10th Australasian Viral Hepatitis Conference 2016
 
*Program subject to change*
29/09/2016 - Thursday
12:30 pm - 1:45 pmRegistration
1:45 pm - 4:00 pmOpening Plenary
Central Room A
Chairperson: Carla Treloar, Professor, Centre for Social Research in Health, UNSW, Australia
Chairperson: Benjamin Cowie, Associate Professor, Doherty Institute, Melbourne, Australia
1:45 pm - 1:55 pmWelcome to Country
Central Room A
Craig Williams, Traditional Owner
1:55 pm - 2:00 pmCommittee Welcome
Central Room A
Krispin Hajkowicz, Senior Lecturer, Infectious Diseases, University of Queensland, Australia
2:00 pm - 2:10 pmGovernment Representative Welcome
Central Room A
The Hon Dr David Gillespie MP, Assistant Minister for Rural Health
2:10 pm - 2:20 pmMy Experience Living with Hepatitis C
Central Room A
Scott
2:20 pm - 2:30 pmMy Experience Living with Hepatitis B
Central Room A
Linh Nguyen
2:30 pm - 3:00 pmTreating Epidemics with Low-Cost Generics
Central Room A
Andrew Hill, Senior Visiting Research Fellow, Pharmacology Department Liverpool University

Presentation

3:00 pm - 3:30 pmThe Future of Hep C Care for People Who Use Drugs: Lessons from a Community-Based, Harm Reduction, Client-Driven Program in Toronto, Canada
Central Room A
Zoe Dodd, co-founder and Program Coordinator, Toronto Community Hep C Program, Toronto, Canada

Abstract

Presentation

3:30 pm - 4:00 pmThe New HCV treatment Era in Australia: Early Lessons
Central Room A
Greg Dore, Head, Kirby Institute, UNSW, Australia
4:00 pm - 4:30 pmAfternoon Tea
Exhibition Hall, Hall 1
4:30 pm - 6:00 pmCross Track Session: How can we provide better services for people with viral hepatitis? (Models of Care)
Central Room A
Chairperson: Emma Day, INHSU Program Manager, Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine, Sydney, Australia
Chairperson: Krispin Hajkowicz, Senior Lecturer, Infectious Diseases, University of Queensland, Australia
Cross Track Session: International Revolution
Room 5
Chairperson: Benjamin Cowie, Associate Professor, Doherty Institute, Melbourne, Australia
Chairperson: Lisa Maher, Program Head and NHMRC Senior Research Fellow, The Kirby Institute, UNSW, Australia
Cross Track Session: Viral Hepatitides Session
Room 6
Chairperson: David Anderson, Deputy Director, Burnet Institute, Melbourne, Australia
Chairperson: Margaret Littlejohn, Senior Medical Scientist, Victorian Infectious Diseases Reference Laboratory, Australia
4:30pm - 4:45pm Report back from MOC Satellite
Central Room A
Krispin Hajkowicz, Senior Lecturer, Infectious Diseases, University of Queensland, Australia

Presentation 

4:30pm - 4:35pm Introduction
Room 5
Benjamin Cowie, Associate Professor, Doherty Institute, Melbourne, Australia

Presentation
4:30pm - 5:00pm Hepatitis A Outbreaks in Australia
Room 6
Scott Bowden, Senior Medical Scientist, Victorian Infectious Diseases Reference Laboratory, Australia

Abstract

Presentation

4:45pm - 5:00pm Liver Disease Burden and Clinical Follow-Up during a Liver Health Promotion Intervention Integrating Non-Invasive Liver Disease Screening in Drug and Alcohol Settings: The Liverlife Study
Central Room A
Jason Grebely, Associate Professor, The Kirby Institute, UNSW, Australia


4:35pm - 4.50pm Australia’s Progress Towards the National Hepatitis Strategy Targets
Room 5
John Kaldor, Professor and Program Head, Kirby Institute, NSW, Australia
5:00pm - 5:15pm Quihn Treatment Management Program: An Evolving HCV Treatment Model for People who Inject Drugs - a Community Prescribing Model in Queensland, Australia
Central Room A
Nik Alexander, Senior Program Manager - Harm Reduction Services, Queensland Injectors Health Network (QuIHN), Australia


4:50pm - 5:05pm UNGASS and Beyond
Room 5
Kathryn Leafe, Executive Director , Needle Exchange Services Trust, New Zealand

Presentation 

5:00pm - 5:30pm - Hepatitis Delta Virus in Australia
Room 6
Kathy Jackson, Senior Scientist, Victorian Infectious Diseases Reference Laboratory, Doherty Institute, Australia


Abstract


5:05pm - 5:20pm International viral hepatitis responses for indigenous peoples
Room 5
James Ward, Head, Infectious Diseases Research Aboriginal and Torres Strait Islander Health, SAHMRI, Australia
5:15pm - 5:30pm One Size Does Not Fit All: Two Hepatitis B Outreach Testing Models
Central Room A
Marina Suarez, Health Promotion Officer, Multicultural HIV and Hepatitis Service, Australia

5:20pm - 5:35pm WHO and hepatitis: what the elimination agenda means for the Region (via Skype)
Room 5
Nick Walsh MD PhD, Medical Officer | Viral Hepatitis, World Health Organization, Philippines
5:30pm - 6:00pm Panel Discussion
Central Room A
Krispin Hajkowicz, Senior Lecturer, Infectious Diseases, University of Queensland, Australia
Jason Grebely, Associate Professor, The Kirby Institute, UNSW, Australia
Nik Alexander, Senior Program Manager - Harm Reduction Services, Queensland Injectors Health Network (QuIHN), Australia
Marina Suarez, Health Promotion Officer, Multicultural HIV and Hepatitis Service, Australia
Zoe Dodd, co-founder and Program Coordinator, Toronto Community Hep C Program, Toronto, Canada
Emma Day, INHSU Program Manager, Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine, Sydney, Australia
5:35pm - 6:00pm Panel Discussion
Room 5
Rebecca Guy, Associate Professor, Kirby Institute, UNSW, Australia
James Ward, Head, Infectious Diseases Research Aboriginal and Torres Strait Islander Health, SAHMRI, Australia
Kathryn Leafe, Executive Director , Needle Exchange Services Trust, New Zealand
Nick Walsh MD PhD, Medical Officer | Viral Hepatitis, World Health Organization, Philippines
Benjamin Cowie, Associate Professor, Doherty Institute, Melbourne, Australia
Lisa Maher, Program Head and NHMRC Senior Research Fellow, The Kirby Institute, UNSW, Australia
5:30pm - 6:00pm - Update on Hepatitis E in Australia
Room 6
David Siebert, Infectious Diseases Physician and microbiologist, Princess Alexandra Hospital, Brisbane
6:00 pm - 8:00 pmWelcome Reception and Poster Viewing
Exhibition Hall, Hall 1
6:10 pm - 6:40 pmLaunch of the Kirby and CSRH Surveillance Reports
Central Room A
Greg Dore, Head, Kirby Institute, UNSW, Australia
Carla Treloar, Professor, Centre for Social Research in Health, UNSW, Australia
James Ward, Head, Infectious Diseases Research Aboriginal and Torres Strait Islander Health, SAHMRI, Australia

30/09/2016 - Friday
6.30 am Registration Opens
7:00 am - 8:45 amBMS Breakfast Satellite Session - HCV Elimination by 2026. Australia leads the world
Central Room A
Moderator: Dr Norman Swan, ABC Health Report
7:00 am - 8:45 amPanellists
Central Room A
Brent Allan, Living Positive Victoria, Melbourne, Australia
Joanne Morgan, Australian Hepatology Association & Royal Adelaide Hospital, Adelaide, Australia
Levinia Crooks, Adjunct Associate Professor, Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine, Sydney, Australia
Mark O’Reilly, Dr, Prahran Market Clinic, Melbourne, Australia
Greg Dore, Head, Kirby Institute, UNSW, Australia
Andrew Lloyd, Professor, Kirby Institute, Prince of Wales Hospital, and Justice Health & Forensic Mental Health Network, New South Wales, Australia
Helen Tyrrell, CEO, Hepatitis Australia, ACT, Australia
9:00 am - 10:30 amPlenary 2
Central Room A
Chairperson: Scott Bowden, Senior Medical Scientist, Victorian Infectious Diseases Reference Laboratory, Australia
Chairperson: Gail Matthews, A/Professor, Kirby Institute, UNSW, Australia
9:00 am - 9:30 amHepatitis Transmission and Prevention: Exploring the Role that the Law Plays in Shaping Blood Borne Virus Epidemics
Central Room A
Kate Seear, ARC DECRA Fellow and Senior Lecturer in Law, Monash University, Victoria, Australia

Abstract

Presentation

9:30 am - 10:00amDeciphering Host Range Restrictions of Human Hepatitis Viruses
Central Room A
Alex Ploss, PhD, Assistant Professor, Princeton University, USA

Abstract

10:00 am - 10:30 amRecommendations for the Management of Hepatitis C Virus Infection: Australian and International Guidelines
Central Room A
Alex Thompson, Director of Gastroenterology, St Vincent's Hospital, Melbourne, Victoria, Australia

Presentation 

10:30 am - 11:00 amMorning Tea
Exhibition Hall, Hall 1
11:00 am - 12:30 pmEpidemiology, Public Health & Prevention - Epidemiology and natural history of hepatitis B & C
Central Room A
Chairperson: Jess Howell, NHMRC Post Doctoral research fellow, Burnet Institute, Australia
Chairperson: Peter Higgs, Senior Lecturer, La Trobe University, Melbourne, Australia
Community & Social Research - Good community responses to priority populations
Central Room C
Chairperson: Christian Vega, Policy & Research Officer, AIVL, Canberra, Australia
Chairperson: Elena Cama, Research Associate, Centre for Social Research in Health at UNSW, Australia
Clinical - Developments in HBV Treatment and Management
Room 5
Chairperson: Simone Strasser, Hepatologist, Royal Prince Alfred Hospital
Chairperson: Paul Clark, Gastroenterologist, Queensland, Australia
Community & Social Research - Culture and engagement - CALD & Indigenous
Room 6
Chairperson: Benjamin Cowie, Associate Professor, Doherty Institute, Melbourne, Australia
Chairperson: Helen Tyrrell, CEO, Hepatitis Australia, ACT, Australia
11:00 am - 11:15 am Prevalence of Hepatitis C among Aboriginal and Torres Strait Islander Australians: A Meta-Analysis
Central Room A
Dr Mary Ellen Harrod, Chief Executive Officer , NSW Users and AIDS Association, Australia

Advocates in Action: The work of Hepatitis Victoria Community Advocates
Central Room C
Ross Williams, Community Advocate, Hepatitis Victoria, Australia
Nafisa Yussf, Community Advocate , Hepatitis Victoria, Australia

11:00am - 11:20am HBV Treatment: Past, Present and the Future
Room 5
Scott Bowden, Senior Medical Scientist, Victorian Infectious Diseases Reference Laboratory, Australia

Presentation

Engaging Diverse Communities in the Response to Hepatitis B: The Hepatitis B Community Alliance NSW
Room 6
Marina Suarez, Health Promotion Officer, Multicultural HIV and Hepatitis Service, Australia



11:15 am - 11:30 am Hepatic Fibrosis and Quality of Life in People Who Inject Drugs with Hepatitis C Virus
Central Room A
Stelliana Goutzamanis, student (honours), The Burnet Institute, Australia

Experiences of Diagnosis, Care and Treatment among Aboriginal People Living with Hepatitis C
Central Room C
Loren Brener, Senior Research Fellow, Centre for Social Research in Health, Australia


11:20am - 11:30am Distance and Disparity
Room 5
Jane Davies, Senior Clinical Research Fellow, Menzies School of Health Research, Australia
“You Know In the Community When They Heard of Something and Then You Can’t Even Be With Them”: Lived Experiences of Chronic Hepatitis B among South Sudanese in Australia
Room 6
William Mude, PhD Candidate, Australian Research Centre for Sex, Health and Society; La Trobe University, Australia


11:30 am - 11:45 am Trends in Hepatocellular Carcinoma, Victoria, Australia, 2004-2013
Central Room A
Kylie Carville, Epidemiologist, WHO Collaborating Centre for Viral Hepatitis VIDRL, Doherty Institute for Infection and Immunity, Australia

Peer Support Increases Access to Hepatitis C Treatment to Care in Drug and Alcohol Settings
Central Room C
Yvonne Samuel, Peer Support Work Coordinator, NSW Users and AIDS Association, Australia

11:30am - 11:40am - Challenges in HBV Treatment and Management
Room 5
Jacqui Richmond, Research Fellow / Clinical Nurse Consultant, La Trobe University / Melbourne Health, Australia

Presentation

Vietnamese Understandings and Responses to Chronic Hepatitis B
Room 6
Roslyn Le, Research Fellow, Australian Research Centre in Sex, Health and Society, La Trobe University, Australia


11:45 am - 12:00 pm Trends in Hepatocellular Carcinoma among People with a HBV or HCV Notification in New South Wales, Australia between 2000 and 2014
Central Room A
Reem Waziry, PhD candidate, The Kirby institute-UNSW, Australia

The Prison Economy of Needles and Syringes: What Opportunities Exist for BBV Risk Reduction When Prices are so High?
Central Room C
Carla Treloar, Professor, Centre for Social Research in Health, UNSW, Australia

11:40am - 12:30pm Case Discussion
Room 5
Scott Bowden, Senior Medical Scientist, Victorian Infectious Diseases Reference Laboratory, Australia
Jane Davies, Senior Clinical Research Fellow, Menzies School of Health Research, Australia
Jacqui Richmond, Research Fellow / Clinical Nurse Consultant, La Trobe University / Melbourne Health, Australia
Moderator: Simone Strasser, Hepatologist, Royal Prince Alfred Hospital
Moderator: Paul Clark, Gastroenterologist, Queensland, Australia
Liverzone
Room 6
Hande Noyan, Care and Support Women's Health Coordinator, Northern Territory AIDS and Hepatitis Council, Australia

Abstract

Presentation 

12:00 pm - 12:15 pm Hepatitis B Prevalence in Communities in the Eastern African region: A Systematic Literature Review
Central Room A
William Mude, PhD Candidate, Australian Research Centre for Sex, Health and Society; La Trobe University, Australia


A Community Collaboration for an Improved Policy Response to BBVS in Australian Prisons
Central Room C
Kevin Marriott, Policy Officer, Hepatitis Australia, Australia

Deadly Grandmothers; Proper Way Partnerships, Supporting Elders Working with Young People in Community
Room 6
Jodie Walton, BBV & STI Education Project Officer, Hepatitis Queensland, Australia


12:15 am - 12: 30 am Discussion
Central Room A
Discussion
Central Room C
Discussion
Room 6
12:30 pm - 1:30 pmLunch
Exhibition Hall, Hall 1
12:50 pm - 1:15pmAHA Adherance Guidelines Launch
Room 5
12:50 pm - 1:15pmCentre for Social Research in Health - Community Consultation
Room 6
1:30 pm - 2:45 pmEpidemiology, Public Health & Prevention - Informing prevention strategies in hepatitis C priority populations
Central Room A
Chairperson: Mark Stoove, Associate Professor , Burnet Institute, Australia
Chairperson: Lisa Maher, Program Head and NHMRC Senior Research Fellow, The Kirby Institute, UNSW, Australia
Community & Social Research - Enhancing Testing and Treatment
Central Room C
Chairperson: Yvonne Drazic, PhD candidate, James Cook University, Australia
Chairperson: Janette Medforth, The Hepatitis Foundation of New Zealand, New Zealand
Clinical - Improving outcomes for antiviral therapy for Hepatitis B
Room 5
Chairperson: Joanne Morgan, Australian Hepatology Association & Royal Adelaide Hospital, Adelaide, Australia
Chairperson: Graeme MacDonald, Senior Staff Specialist, PA-Southside Clinical School, The University of Queensland, Princess Alexandra Hospital, Australia

Presentation 

Basic Science - HBV
Room 6
Chairperson: Peter Revill, Senior Medical Scientist, Victorian Infectious Diseases Reference Laboratory (VIDRL), Doherty Institute, Victoria, Australia
Chairperson: Scott Bowden, Senior Medical Scientist, Victorian Infectious Diseases Reference Laboratory, Australia
1:30 pm - 1:45 pmAssociations with Hepatitis C Virus Infection among Men Who Have Sex with Men in Vietnam
Central Room A
Nghia Khuu, Head of HIV/AIDS Unit , The Pasteur Institute, Ho Chi Minh City, Vietnam

Abstract

Qualitative Evaluation of the Decisions and Experiences of People Who Inject Drugs Who Received a Liver Disease Assessment as Part of a Liver Health Promotion Campaign: The Liverlife Study
Central Room C
Carla Treloar, Professor, Centre for Social Research in Health, UNSW, Australia


Yes We Can! Optimising Treatment and Management of Chronic Hepatitis B Based on a Disease Registry
Room 5
Ximena Masgoret, Research Assistant, Cancer Council, NSW, Australia



HBV Core Promoter Mutants Activate Pi3k/AKT Signalling In Cell Culture, Promoting Hepatocarcinogenesis
Room 6
Anis Khan, Postdoctoral Scientist, The Westmead Institute for Medical Research, Australia


1:45 pm - 2:00 pmStable Incidence of Hepatitis C Virus Infection among People with a History of Injecting Drug Use in an Australian Prison Setting, 2005-2014: The HITS-P Study
Central Room A
Evan Cunningham, PhD Candidate, Kirby Institute - UNSW, Australia


Hepatitis B Testing and Diagnosis Experiences of People with Hepatitis B and Health Professionals
Central Room C
Jacqui Richmond, Research Fellow / Clinical Nurse Consultant, La Trobe University / Melbourne Health, Australia

The ‘B in It’ Programme - Community Based Care of Chronic Hepatitis B Patients Using a Novel Online Clinical Guide
Room 5
Debra O'Leary, Project Officer, St Vincent's Hospital Melbourne, Australia


Viral Kinetic are Significantly Different In Basal Core Promoter and Precore Variants of Hepatitis B
Room 6
Zina Valaydon, Gastroenterologist & PhD Fellow, St Vincent's Hospital and VIDRL, Australia

2:00 pm - 2:15 pmModelling Hepatitis C Virus Transmission in a High-Risk Incarcerated Population
Central Room A
Neil Bretana, PhD student, UNSW, Australia


Hepatitis B Clinical Specialists: Responding to Cultural Diversity
Central Room C
Jack Wallace, Research Fellow, Australian Research Centre in Sex, Health and Society, Australia

Supporting Patients with Chronic Hepatitis B: Improving the Patient Experience through a Shared Model of Care
Room 5
Kristen Stone, Clinical Nurse Specialist, Storr Liver Centre, Westmead Hospital, Australia

Deep Sequencing Shows that the Presence of HBV BCP/Pc Variants Reduces the Rate of HBSAG Loss among HBEAG-Positive CHB Patients Treated with Long-Term Tenofovir DF Therapy
Room 6
Margaret Littlejohn, Senior Medical Scientist, Victorian Infectious Diseases Reference Laboratory, Australia



2:15 pm - 2:30 pmHepatitis C Virus Exposure, Infection and Associated Risk Behaviours in Two Maximum-Security Prisons in New South Wales, Australia
Central Room A
Behzad Hajari, Associate Lecturer, UNSW, Australia

Abstract
Engaging Affected Communities in Treatment Advocacy Campaigning
Central Room C
David Pieper, Campaigns Coordinator, Hepatitis NSW, Australia


Viral Outcomes in Patients with Chronic Hepatitis B and Correlation with Pharmacy Adherence Measures
Room 5
Nicole Allard, General Practitioner, Doherty, Melbourne, Australia


Molecular Epidemiology of Hepatitis Delta Virus in Oceania
Room 6
Kathy Jackson, Senior Scientist, Victorian Infectious Diseases Reference Laboratory, Doherty Institute, Australia

Abstract
2:30 pm - 2:45pmDiscussion
Central Room A
Discussion
Central Room C
Concordance between Missed Days of Hepatitis B Virus Anti-Viral Therapy and Virological Breakthrough
Room 5
Suzanne Sheppard-Law, Senior Research Fellow, University of Technology Sydney/Sydney Children's Hospital Network, Australia

Abstract

An Immunochromatographic Test for Measurement of Alanine Aminotransferase (ALT) at Point of Care
Room 6
David Anderson, Deputy Director, Burnet Institute, Melbourne, Australia


2:45 pm - 3:05 pmAfternoon Tea
Exhibition Hall, Hall 1
3:05 pm - 4:25 pmEpidemiology, Public Health & Prevention - Burden of Hepatitis B and Hepatitis C infections globally and in Australia
Central Room A
Chairperson: Nicole Allard, General Practitioner, Doherty, Melbourne, Australia
Chairperson: Jason Grebely, Associate Professor, The Kirby Institute, UNSW, Australia
Community & Social Research - Stigma and other barriers to healthcare in the lives of people who inject drugs and those living with Hepatitis C
Central Room C
Chairperson: Kate Seear, ARC DECRA Fellow and Senior Lecturer in Law, Monash University, Victoria, Australia
Chairperson: Christian Vega, Policy & Research Officer, AIVL, Canberra, Australia
Clinical - Difficult Scenarios for HCV management
Room 5
Chairperson: Graeme MacDonald, Senior Staff Specialist, PA-Southside Clinical School, The University of Queensland, Princess Alexandra Hospital, Australia
Chairperson: Krispin Hajkowicz, Senior Lecturer, Infectious Diseases, University of Queensland, Australia
Basic Science - Is elimination of hepatitis C possible without a vaccine?
Room 6
Chairperson: Tanya Applegate, Senior Lecturer, The Kirby Institute, UNSW, Australia
Chairperson: Heidi Drummer, Laboratory Head, Burnet Institute, Australia
3:05pm - 3:10pm Launch of the Third National Hepatitis B Mapping Report
Central Room A
Benjamin Cowie, Associate Professor, Doherty Institute, Melbourne, Australia

Presentation
3:05pm - 3:20pm Stigma among People Living With Hepatitis C and People Who Inject Drugs in Australia
Central Room C
Elena Cama, Research Associate, Centre for Social Research in Health at UNSW, Australia

3:05pm - 3:15pm Difficult scenarios for HCV management
Room 5
Ed Gane, Professor of Medicine, University of Auckland, New Zealand

Presentation

3:05pm - 3:35pm Gaps in Experimental Systems Required for Preclinical Testing of HCV Vaccine Candidates
Room 6
Alex Ploss, PhD, Assistant Professor, Princeton University, USA
3:10pm - 3:25pm Global Burden
Central Room A
Benjamin Cowie, Associate Professor, Doherty Institute, Melbourne, Australia

Presentation

3:20pm - 3:35pm Beyond the ‘Empty Warehouse’: Exploring Barriers and Facilitators for Reaching Those ‘Next In Line’ For the New HCV Treatments
Central Room C
Angella Duvnjak, Program Manager, Australian Injecting and Illicit Drug Users League, Australia

3:15pm - 3:25pm Difficult scenarios for HCV management
Room 5
Olivia Cullen, Clinical nurse consultant , Royal Brisbane and Women’s Hospital, Australia
3:35pm - 4:00pm Modelling HCV Elimination: Is it Achievable What Role Would a Vaccine Play
Room 6
Nick Scott, Econometrician , Burnet Institute, Australia

Presentation 

3:25pm - 3:40pm HCC epidemiology in Australia- A tale of two cities
Central Room A
Paul Clark, Gastroenterologist, Queensland, Australia
3:35pm - 3:50pm Stigma, Discrimination & People Who Inject Drugs: Genuine access to new hepatitis C treatments
Central Room C
Yvonne Samuel, Peer Support Work Coordinator, NSW Users and AIDS Association, Australia

Presentation 

3:25pm - 3:35pm Difficult scenarios for HCV management
Room 5
Gail Matthews, A/Professor, Kirby Institute, UNSW, Australia
4:00pm - 4:25pm Myanmar global perspective on DAAs and vaccines
Room 6
Mark Stoove, Associate Professor , Burnet Institute, Australia

Presentation 

3:40pm - 3:55pm Estimating populations PWID
Central Room A
Sarah Larney, Senior Research Fellow, National Drug and Alcohol Research Centre, University of New South Wales, Australia

Presentation

3:50pm - 4:05pm Reducing Barriers | NZ experiences
Central Room C
Kathryn Leafe, Executive Director , Needle Exchange Services Trust, New Zealand
3:35pm - 4:25pm Case Discussion - Panel
Room 5
Moderator: Graeme MacDonald, Senior Staff Specialist, PA-Southside Clinical School, The University of Queensland, Princess Alexandra Hospital, Australia
Moderator: Krispin Hajkowicz, Senior Lecturer, Infectious Diseases, University of Queensland, Australia
Ed Gane, Professor of Medicine, University of Auckland, New Zealand
Olivia Cullen, Clinical nurse consultant , Royal Brisbane and Women’s Hospital, Australia
Greg Dore, Head, Kirby Institute, UNSW, Australia
3:55pm - 4:10pm Estimating the burden of hepatitis B infection in Aboriginal and Torres Strait Islander People
Central Room A
Jane Davies, Senior Clinical Research Fellow, Menzies School of Health Research, Australia

Presentation

4:05pm - 4:25pm- Panel Discussion
Central Room C
Kate Seear, ARC DECRA Fellow and Senior Lecturer in Law, Monash University, Victoria, Australia
Christian Vega, Policy & Research Officer, AIVL, Canberra, Australia
Elena Cama, Research Associate, Centre for Social Research in Health at UNSW, Australia
Angella Duvnjak, Program Manager, Australian Injecting and Illicit Drug Users League, Australia
Kathryn Leafe, Executive Director , Needle Exchange Services Trust, New Zealand
Yvonne Samuel, Peer Support Work Coordinator, NSW Users and AIDS Association, Australia
4:10pm - 4:25pm Panel Discussion
Central Room A
Benjamin Cowie, Associate Professor, Doherty Institute, Melbourne, Australia
Sarah Larney, Senior Research Fellow, National Drug and Alcohol Research Centre, University of New South Wales, Australia
Margaret Hellard, Professor, Burnet Institute, Melbourne, VIC, Australia
Melanie Eagle, Chief Executive Officer , Hepatitis Victoria, VIC, Australia
Yvonne Drazic, PhD candidate, James Cook University, Australia
Nicole Allard, General Practitioner, Doherty, Melbourne, Australia
Jason Grebely, Associate Professor, The Kirby Institute, UNSW, Australia
Paul Clark, Gastroenterologist, Queensland, Australia
Jane Davies, Senior Clinical Research Fellow, Menzies School of Health Research, Australia
4:30 pm - 5:00 pmPlenary 3
Central Room A
Chairperson: Helen Tyrrell, CEO, Hepatitis Australia, ACT, Australia
Chairperson: Susan Hay, Acting Chief Executive Officer, The Hepatitis Foundation of NZ,New Zealand
4:30 pm - 5:00 pmGlobal Strategies are Required to Cure and Eliminate HBV
Central Room A
Peter Revill, Senior Medical Scientist, Victorian Infectious Diseases Reference Laboratory (VIDRL), Doherty Institute, Victoria, Australia

Abstract

5:00 pm - 5:30 pmWe have Perfectovir - do we need anything else?
Central Room A
Ed Gane, Professor of Medicine, University of Auckland, New Zealand


5:00 pm - 10:30 pmConference Dinner - Depart from Gold Coast Convention & Exhibition Centre
McLarens Landing

01/10/2016 - Saturday
7:00 am Registration Opens
7:30 am - 9:15 amCuring HCV - Leave no Patient Behind - AbbVie Breakfast Satellite Session
Central Room A
Chairperson: Simone Strasser, Hepatologist, Royal Prince Alfred Hospital
8:00 am - 8:05 amIntroduction
Central Room A
Simone Strasser, Hepatologist, Royal Prince Alfred Hospital
8:05 am - 8:25 amCuring the Co-infected in the Community
Central Room A
Dr Phillip Read, Kirketon Road Centre, Australia
8:25am - 8:45 amTaking Treatment to the Patient – Beyond traditional settings
Central Room A
Jana Van der Jagt, Dr, Port Macquarie Hospital, Australia
8:45am - 9:05 amThe Legacy of Resistance Associated Substitutions
Central Room A
Alex Thompson, Professor, Australian Liver Association & St Vincent’s Hospital, Melbourne, Australia
9:05 am - 9:10 amClosing Remarks
Central Room A
Simone Strasser, Hepatologist, Royal Prince Alfred Hospital
9:30 am - 11:00 am Epidemiology, Public Health & Prevention - Strategies to enhance the Hepatitis B and C Care Cascades
Central Room A
Chairperson: Andrew Hill, Senior Visiting Research Fellow, Pharmacology Department Liverpool University
Chairperson: Lisa Maher, Program Head and NHMRC Senior Research Fellow, The Kirby Institute, UNSW, Australia
Community & Social Research -Communities responding to hepatitis B: barriers, enablers and experiences
Central Room C
Chairperson: Jack Wallace, Research Fellow, Australian Research Centre in Sex, Health and Society, Australia
Chairperson: Enaam Oudih, Practice Manager, Multicultural Services,Manager BBV programs, Manager Multicultural Gambling Health Service, Relationships Australia, SA, Australia
Clinical - Fibrosis Assessment
Room 5
Chairperson: Ken Koh, GP, Holdsworth House, Australia
Jeremy Hayllar, Clinical Director, Metro North Mental Health - Alcohol and Drug Service, Brisbane, Australa
Basic Science - Eliminate hepatitis B: A multi-pronged approach is required
Room 6
Chairperson: Heidi Drummer, Laboratory Head, Burnet Institute, Australia
Chairperson: Mark Douglas, Associate Professor, University of Sydney, Australia
9:30am - 9:45am Interventions to Enhance Hep C cascade
Central Room A
Jason Grebely, Associate Professor, The Kirby Institute, UNSW, Australia

Presentation

9:30am - 10:00am Cross Cultural Community Engagement Matters
Central Room C
Enaam Oudih, Practice Manager, Multicultural Services,Manager BBV programs, Manager Multicultural Gambling Health Service, Relationships Australia, SA, Australia

Presentation 

9:30am - 10:00am Non-Invasive Assessment of Liver Fibrosis
Room 5
Joseph Doyle, Co-Head, Hepatitis Research, Burnet Institute, Australia
9:30am - 10:00am Global Strategies are required to cure and eliminate HBV
Room 6
Peter Revill, Senior Medical Scientist, Victorian Infectious Diseases Reference Laboratory (VIDRL), Doherty Institute, Victoria, Australia

Abstract

9:45am - 10:00am Interventions to Enhance Hep B Cascade
Central Room A
Jennifer MacLachlan, Epidemiologist, WHO Collaborating Centre for Viral Hepatitis, The Doherty Institute, Australia

Presentation 

10:00am - 10:30am Deadly Grandmothers: Hepatitis QLD
Central Room C
Jodie Walton, BBV & STI Education Project Officer, Hepatitis Queensland, Australia
10:00am - 10:30am Community Assessment of Fibrosis in Primary Care and Rural Settings
Room 5
Annie Balcomb, General Practitioner, Prince St Medical Practice, Australia

Presentation

10:00am - 10:30am Nucleos(t)ide analogues for chronic hepatitis B: Cessation of treatment
Room 6
Alex Thompson, Director of Gastroenterology, St Vincent's Hospital, Melbourne, Victoria, Australia

Presentation

10:00am - 10:10am The Use of Surveillance Systems to Improve Diagnosis and Testing tor Hepatitis B and C
Central Room A
Margaret Hellard, Professor, Burnet Institute, Melbourne, VIC, Australia

Presentation

10:30am - 11:00am Panel Discussion
Central Room C
Jack Wallace, Research Fellow, Australian Research Centre in Sex, Health and Society, Australia
Enaam Oudih, Practice Manager, Multicultural Services,Manager BBV programs, Manager Multicultural Gambling Health Service, Relationships Australia, SA, Australia
Cindy Shannon, Pro-Vice-Chancellor, The University of Queensland, Australia
Barbara Luisi, Manager, NSW Multicultural HIV and Hepatitis Service, NSW, Australia
10:30am - 11:00am HCV DAA Imports Failing to Deliver Results: SVR12 outcomes for imported DAA;s in the NT.
Room 5
Matthew Maddison, Hepatitis C Clinical Nurse Consultant, Royal Darwin Hospital, NT, Australia

Presentation

10:30am - 11:00am Hepatitis B vaccination in the era of elimination
Room 6
Benjamin Cowie, Associate Professor, Doherty Institute, Melbourne, Australia
10:10am - 10:20am Simplification of HCV Diagnostic Strategies
Central Room A
Tanya Applegate, Senior Lecturer, The Kirby Institute, UNSW, Australia
10:20am - 10:30am Health Promotion Interventions in A&TSI
Central Room A
Kerri-Anne Smith, Aboriginal Hepatitis C Health Promotion Officer, Western Sydney Local Health District, Needle and Syringe Program, Australia
Carla Treloar, Professor, Centre for Social Research in Health, UNSW, Australia

Presentation

10:30am - 10:40am Health Promotion Interventions in PWID
Central Room A
Christian Vega, Policy & Research Officer, AIVL, Canberra, Australia
10:40am - 11:00am Panel Discussion - Future Research Priorities for Understanding Strategies to Enhance the Hepatitis B and C Care Cascade in Australia
Central Room A
Andrew Hill, Senior Visiting Research Fellow, Pharmacology Department Liverpool University
Lisa Maher, Program Head and NHMRC Senior Research Fellow, The Kirby Institute, UNSW, Australia
Jason Grebely, Associate Professor, The Kirby Institute, UNSW, Australia
Jennifer MacLachlan, Epidemiologist, WHO Collaborating Centre for Viral Hepatitis, The Doherty Institute, Australia
Margaret Hellard, Professor, Burnet Institute, Melbourne, VIC, Australia
Kerri-Anne Smith, Aboriginal Hepatitis C Health Promotion Officer, Western Sydney Local Health District, Needle and Syringe Program, Australia
Christian Vega, Policy & Research Officer, AIVL, Canberra, Australia
Tanya Applegate, Senior Lecturer, The Kirby Institute, UNSW, Australia
11.00 am - 11.30 amMorning Tea
Exhibition Hall, Hall 1
11.30 am - 1.00 pmEpidemiology, Public Health & Prevention - Improving access to testing and care
Central Room A
Chairperson: Annie Balcomb, General Practitioner, Prince St Medical Practice, Australia
Community & Social Research - On the Road to Elimination
Central Room C
Chairperson: Cindy Shannon, Pro-Vice-Chancellor, The University of Queensland, Australia
Chairperson: Zoe Dodd, co-founder and Program Coordinator, Toronto Community Hep C Program, Toronto, Canada
Clinical - Hepatitis C Antiviral Therapy: Reaching out in the new Era
Room 5
Chairperson: Barbara Leggett, Medical Specialist, Royal Brisbane and Womens Hospital, Australia
Chairperson: Mary Fenech, Nurse, Queensland Health, Australia
Basic Science - Understanding HCV Transmission, Immunity and Diagnosis
Room 6
Chairperson: Margaret Littlejohn, Senior Medical Scientist, Victorian Infectious Diseases Reference Laboratory, Australia
Chairperson: Scott Bowden, Senior Medical Scientist, Victorian Infectious Diseases Reference Laboratory, Australia
11:30 am - 11:45 amUsing a Knowledge Translation Approach to Increase Testing of Patients at Risk of Hepatitis B in a Primary Health Setting
Central Room A
Jacqui Richmond, Research Fellow / Clinical Nurse Consultant, La Trobe University / Melbourne Health, Australia

Advocacy for Universal Access to Hepatitis C Medicines
Central Room C
Helen Tyrrell, CEO, Hepatitis Australia, ACT, Australia

An Integrated Primary Health Care Service Is Effective at Retaining and Linking Marginalised Groups In Hepatitis C Care: A Study of The Kirketon Road Centre, Kings Cross
Room 5
Rosie Gilliver, Projects Manager/Clinical Nurse Consultant , Kirketon Road Centre, Kings Cross, Sydney, Australia

Commitment to CD8+ T Cell Exhaustion and Loss of Memory T Cell Potential Develops during Primary Chronic HCV Infection
Room 6
Mehdi Rasoli Pirozyan, PhD Student, University of New South Wales, Australia


11:45 am - 12:00pmResponding To Notifications of Unspecified Hepatitis B and C in Victoria
Central Room A
Nicole Romero, Epidemiologist, WHO Collaborating Centre for Viral Hepatitis, VIDRL, Doherty Institute, Australia

Implementing the Hepatitis C Cure: The Public Health Implications
Central Room C
Jack Wallace, Research Fellow, Australian Research Centre in Sex, Health and Society, Australia

The Dog at my Daclatasvir: Real Life Experiences Delivering Direct Acting Antivirals to Marginalised, Homeless, and Active Drug Users
Room 5
Rebecca Lothian, Clinical nurse specialist and is the Hepatitis C Treatment Coordinator , Kirketon Road Centre

Refolding the Hepatitis C Virus E2 Glycoprotein to Enhance Immunogenicity
Room 6
Lilian Phu, Research Assistant, Burnet Institute, Australia

12:00 pm - 12:15 pmPopulating the Hepatitis C Testing, Care and Treatment Cascade among People who Inject Drugs in Australia
Central Room A
Lisa Maher, Program Head and NHMRC Senior Research Fellow, The Kirby Institute, UNSW, Australia

Relationships Matter: Social Capital Theory and the Delivery of Hepatitis C Treatment in Prison
Central Room C
Lise Lafferty, PhD Candidate, The Kirby Institute, UNSW, Australia

Treatment Uptake for Chronic Hepatitis C in Australia Following Availability of Interferon-Free Treatments
Room 5
Behzad Hajari, Associate Lecturer, UNSW, Australia
Trends of Hepatitis C Virus Epidemic in Australia and North America in 20th Century: Back Projections from Molecular Epidemiology
Room 6
Chaturaka Rodrigo, PhD Student, School of Medical Sciences, UNSW, Australia

12:15 pm - 12:30 pmThe Cascade of Care for Chronic Hepatitis B, Australia, 2013-2014
Central Room A
Jennifer MacLachlan, Epidemiologist, WHO Collaborating Centre for Viral Hepatitis, The Doherty Institute, Australia

Cairns Hep C Free by 2020
Central Room C
Carla Gorton, HIV, Viral Hepatitis, Sexual Health Coordinator, Cairns Sexual Health Service, Australia


Recruitment and Follow-Up of People Who Inject Drugs into a Nurse-Led HCV Treatment Trial
Room 5
Sally Von Bibra, Research Officer, Burnet Institute, Australia

Modelling the Effects of Targeted DAA Hepatitis C Virus Treatment Strategies Using a Molecular Transmission Network of People with Recent Infection
Room 6
Sofia Bartlett, Postgraduate Research Candidate, The Kirby Institute, Australia


12:30 pm - 12:45 pmA Survey of Hepatitis C Management by Victorian General Practitioners Post Pharmaceutical Benefits Scheme Listing of Direct Acting Antiviral Therapy
Central Room A
Amanda Wade, NHMRC PhD Student, Burnet Institute and Monash University, Australia

Prevalence and Correlates of Hepatitis C among Attendees at New Zealand Needle Exchanges: Results of the 2013 Seroprevalence Survey
Central Room C
Geoff Noller, Director / Research Consultant, Substance Use and Policy Analysis, New Zealand

Curing Hepatitis C in General Practice: The First 60 Days
Room 5
David Baker, General Practitioner, East Sydney Doctors, Australia

Hepatitis C Virus Core Antigen: A Simplified Treatment Monitoring Tool among those with Recent HCV Infection, Including for Post-Treatment Relapse
Room 6
Tanya Applegate, Senior Lecturer, The Kirby Institute, UNSW, Australia


12:45 pm - 1:00 pmDiscussion
Central Room C
Prevalence of Antiviral Resistance in an Australian Hepatitis C Population
Room 5
Mark Douglas, Associate Professor, University of Sydney, Australia


Hepatitis C Virus Core Antigen and Dried Blood Spots as Simplified Hepatitis C Virus Diagnostic Tools
Room 6
Francois Lamoury, Research Officer, The Kirby Institute, UNSW, Australia

1:00 pm - 1:45 pmLunch
Exhibition Hall, Hall 1
1:45 pm - 2:30 pmClosing Plenary: Panel Discussion - You can't ask that! Aus vs NZ: Who will win the elimination race?
Central Room A
Carla Treloar, Professor, Centre for Social Research in Health, UNSW, Australia
Ed Gane, Professor of Medicine, University of Auckland, New Zealand
Moderator: Zoe Dodd, co-founder and Program Coordinator, Toronto Community Hep C Program, Toronto, Canada
Moderator: Andrew Hill, Senior Visiting Research Fellow, Pharmacology Department Liverpool University
Susan Hay, Acting Chief Executive Officer, The Hepatitis Foundation of NZ,New Zealand
Michael Wilson, Programme Manager, Northern Region Hepatitis C Programme, Northern Regional Alliance Limited, New Zealand
Stuart Loveday, Chief Executive Officer , Hepatitis NSW, Australia
Joanne Morgan, Australian Hepatology Association & Royal Adelaide Hospital, Adelaide, Australia
2:30pm - 2:45 pmClosing Remarks
Central Room C
Benjamin Cowie, Associate Professor, Doherty Institute, Melbourne, Australia
2:45 pm - 2:45 pmConference Close